Who owns REVIVA PHARMACEUTCLS HLDGS I?
- Ticker: RVPH
- CUSIP Number: 76152g100
Tip: Access positions for across all investors
Analyze quarterly positions in Reviva Pharmaceutcls Hldgs I with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Reviva Pharmaceutcls Hldgs I stock
Who bought or sold REVIVA PHARMACEUTCLS HLDGS I this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Woodline Partners | 1.1M | $4.0M | 100% | Mar 2024 |
|
| Vanguard Group | 1.0M | $3.8M | 3% | Mar 2024 |
|
| Millennium Management | 855k | $3.2M | 0% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 827k | $3.1M | 100% | Mar 2024 |
|
| Parkman Healthcare Partners | 504k | $1.9M | 100% | Mar 2024 |
|
| Susquehanna International | 500k | $1.9M | -43% | Mar 2024 |
|
| Geode Capital Management | 220k | $832k | 29% | Mar 2024 |
|
| Colony | 171k | $646k | 41% | Mar 2024 |
|
| Citadel Advisors | 165k | $625k | -51% | Mar 2024 |
|
| Polar Securities | 155k | $585k | 0% | Mar 2024 |
|
| EMC Capital Management | 124k | $638k | 0% | Dec 2023 |
|
| BlackRock | 92k | $347k | 4% | Mar 2024 |
|
| Northern Trust | 50k | $191k | 61% | Mar 2024 |
|
| Jpmorgan Chase & Co | 39k | $146k | 4116% | Mar 2024 |
|
| Marshall Wace | 35k | $132k | -11% | Mar 2024 |
|
| Jane Street | 30k | $114k | 3% | Mar 2024 |
|
| Bank of America Corporation | 22k | $83k | 46% | Mar 2024 |
|
| Qube Research & Technologies | 22k | $81k | 611% | Mar 2024 |
|
| Virtu Financial | 15k | $78k | 100% | Dec 2023 |
|
| Vontobel Holding | 14k | $53k | 0% | Mar 2024 |
|
| Northwestern Mutual Wealth Management Company | 9.3k | $35k | 0% | Mar 2024 |
|
| UBS Group | 8.1k | $31k | 100% | Mar 2024 |
|
| Morgan Stanley | 5.6k | $21k | 1022% | Mar 2024 |
|
| Wolverine Asset Management | 3.4k | $13k | -27% | Mar 2024 |
|
| Cutler | 3.0k | $11k | 0% | Mar 2024 |
|
| Archer Investment Corp | 500.00 | $1.9k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 175.00 | $662.007500 | 26% | Mar 2024 |
|
Who sold out of Reviva Pharmaceutcls Hldgs I?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Armistice Capital | Sep 2023 | 600k | $2.9M |
| Rosalind Advisors | Dec 2023 | 196k | $1.0M |
| Belvedere Trading | Sep 2023 | 134k | $652k |
| Group One Trading | Sep 2023 | 129k | $631k |
| Caption Management | Dec 2023 | 116k | $595k |
| Boothbay Fund Management | Sep 2023 | 110k | $535k |
| Man Group | Dec 2023 | 49k | $253k |
| Simplex Trading | Dec 2023 | 45k | $232k |
| Two Sigma Investments | Dec 2023 | 42k | $214k |
| Torno Capital | Dec 2023 | 13k | $65k |
| ADAR1 Capital Management | Dec 2023 | 2.5k | $13k |